Measles, mumps, rubella, and varicella combination vaccine: Safety and immunogenicity alone and in combination with other vaccines given to children

Clinical Infectious Diseases

Volumn 24, Issue 5, 1997, Pages 925-931

  White, C Jo ^a,b   Stinson, Diane ^a   Stachle, Brenda ^a   Cho, Iksung ^a   Matthews, Holly ^a   Ngai, Angela ^a   Keller, Paul ^a   Eiden, Joseph ^a,c   Kuter, Barbara ^a  

^a MERCK RESEARCH LABORATORIES   (United States)

^b North American Vaccine Inc   (United States)

^c NOVARTIS PHARMA AG   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

CHICKENPOX VACCINE; DIPHTHERIA PERTUSSIS TETANUS VACCINE; MEASLES MUMPS RUBELLA VACCINE; ORAL POLIOMYELITIS VACCINE;

ARTICLE; ASTHENIA; CHICKENPOX; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIPHTHERIA; FATIGUE; FEVER; HUMAN; INTRAMUSCULAR DRUG ADMINISTRATION; IRRITABILITY; MAJOR CLINICAL STUDY; MEASLES; MEASLES VIRUS; MULTICENTER STUDY; MUMPS; MUMPS VIRUS; ORAL DRUG ADMINISTRATION; PERTUSSIS; PHASE 3 CLINICAL TRIAL; POLIOMYELITIS; POLIOMYELITIS VIRUS; PRESCHOOL CHILD; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RASH; RUBELLA; RUBELLA VIRUS; SEROCONVERSION; SUBCUTANEOUS DRUG ADMINISTRATION; TETANUS; VARICELLA ZOSTER VIRUS;

EID: 0030901680     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1093/clinids/24.5.925     Document Type: Article

References (19)

1. Weibel RE, Neff BJ, Kuter BJ, et al. Live attenuated varicella virus vaccine: efficacy trial in healthy children. N Engl J Med 1984;310:1409-15.
2. Weibel RE, Kuter BJ, Neff BJ, et al. Live Oka/Merck varicella vaccine in healthy children: further clinical and laboratory assessment. JAMA 1985;254:2435-9.
3. Johnson C, Rome LP, Stancin T, Kumar ML. Humoral immunity and clinical reinfections following varicella vaccine in healthy children. Pediatrics 1989;84:418-21.
4. White CJ, Kuter BJ, Hildebrand CS, et al. Varicella vaccine (VARIVAX®) in healthy children and adolescents: results from clinical trials, 1987-1989. Pediatrics 1991;87:604-10.
5. White CJ, Kuter BJ, Ngai AL, et al. Modified cases of chickenpox after varicella vaccination: correlation of protection with antibody response. Pediatr Infect Dis J 1992;11:19-23.
6. Watson BM, Piercy SA, Plotkin SA, Starr SE. Modified chickenpox in children immunized with the Oka/Merck varicella vaccine. Pediatrics 1993;91:17-22.
7. Bernstein HH, Rothstein EP, Pennridge Pediatric Associates, et al. Clinical survey of natural varicella compared with breakthrough varicella after immunization with live attenuated Oka/Merck varicella vaccine. Pediatrics 1993;92:833-7.
8. Plotkin SA, Starr SE, Conner K, Morton D. Zoster in normal children after varicella vaccine [letter]. J Infect Dis 1989;159:1000-1.
9. Watson B, Gupta R, Randall T, Starr S. Persistence of cell-mediated and humoral immune responses in healthy children immunized with live attenuated vasicella vaccine. J Infect Dis 1994;169:197-9.
10. Kuter BJ, Weibel RE, Guess HA, et al. Oka/Merck varicella vaccine in healthy children - final report of a 2-year efficacy study and 7-year follow-up studies. Vaccine 1991;9:643-7.
11. Lieu TA, Cochi SL, Black SB, et al. Cost-effectiveness of a routine varicella vaccination program for US children. JAMA 1994;271:375-81.
12. Arbeter AM, Baker L, Starr SE, Levine BL, Books E, Plotkin SA. Combination measles, mumps, rubella, and varicella vaccine. Pediatrics 1986;78(suppl):742-7.
13. Brunell PA, Novelli VM, Lipton SV, Pollack B. Combination vaccine against measles, mumps, rubella and varicella. Pediatrics 1988;81:779-84.
14. II package insert. 49th ed. Oradell, New Jersey: Medical Economics, 1995:1687-9.
15. Physicians' desk reference. ORIMUNE® package insert. 49th ed. Oradell, New Jersey: Medical Economics, 1995:1388-90.
16. Physicians' Desk Reference. ACEL-IMUNE® package insert. Oradell, New Jersey: Medical Economics, 1995:1364-7.
17. Hilleman MR, Buynak EB, Weibel RE, Stokes J Jr, Whitman JE Jr, Leagus MB. Development and evaluation of the Moraten measles virus vaccine. JAMA 1968;206:587-90.
18. Shehab ZM, Brunei! PA, Cobb E. Epidemiological standardization of a test for susceptibility to mumps. J Infect Dis 1984;149:810-2.
19. Weibel RE, Stokes J Jr, Buynak EB, Whitman JE Jr, Hilleman MR. Live attenuated mumps-virus vaccine. 3. Clinical and serologic aspects in a field evaluation. N Engl J Med 1967;276:245-51.